Christian Hogg, CEO of Chi-Med says that China's traditional medicine industry is experiencing strong growth and his firm is focused on developing such botanical drugs for the the U.S. and European markets. He talks to Han De Jong of ABN Amro Private Banking and CNBC's Martin Soong and Karen Tso.
http://www.cnbc.com/id/15840232?video=1468344304&play=1
No comments:
Post a Comment